Status:
COMPLETED
Dose-Response Effect Exercise and Depression
Lead Sponsor:
University of Central Florida
Collaborating Sponsors:
American College of Sports Medicine
Conditions:
Depression
Eligibility:
All Genders
18-25 years
Phase:
NA
Brief Summary
The present study aims to address gaps in the literature by evaluating the objectively measured dose-response relationship between exercise and depression symptoms; examining changes in resting (Brain...
Detailed Description
This 10-week randomized single-blind controlled trial will consist of an exercise intervention and attention control condition. A two-week familiarity trial period will be followed by 8 weeks of struc...
Eligibility Criteria
Inclusion
- enrolled UCF college students aged 18 to 25
- mild to moderate depressive symptoms
- willing to wear a Fitbit for extended periods of time during the study
- willing to participate in moderate-to-vigorous PA
- physically able to participate in exercise safely
Exclusion
- under 110 lbs
- history of bad reaction to a past blood draw
- have been advised by a medical provider to not give/donate blood
- presence of anemia
- current cognitive therapy or antidepressant medication
- diagnosis of a co-occurring condition such as attention deficit hyperactivity disorder (ADHD)
- diagnosis of a serious mental illness (SMI) such as schizophrenia or bipolar disorder
- pregnant or nursing
- current smoker
- beta-blocker medications
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT06166095
Start Date
July 1 2023
End Date
December 1 2024
Last Update
March 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Central Florida
Orlando, Florida, United States, 32816